- BREAKING NEWS: CMS Announces Coverage Change to Allow Use of CGM Smart Phone Applications
In an important advocacy victory for our members and their patients, we are encouraged to see that Medicare beneficiaries will be able to use smart phone applications in conjunction with their continuous glucose monitors. - Q&A: Daniel Drucker, MD, New Editor-in-Chief, Endocrine Reviews
Beginning July 1, Daniel J. Drucker, MD, will become the new editor-in-chief of Endocrine Reviews. - High Fear of Disease Occurrence, Low Quality of Life Associated Multiple Endocrine Neoplasia Type 1
- Case of the Month: Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline Educational Activity
- Thyroid Dysfunction May Lead to Diabetes during Pregnancy
Early Registration is now open for Endocrine Board Review 2018 taking place September 4–5 in Miami, Florida.
Clinical Endocrinology Update (CEU) will provide you with the opportunity to learn from and network with faculty at the forefront of endocrine practice and research. Early Registration is now open for:
The Endocrine News Podcast, features interviews with experts addressing the latest research and trends in the field of endocrinology.
We unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide.
Conditional removal of Ndst1-3 in the uterus leads to female infertility due to implantation defects.
We report a negative association between INSL3 and sclerostin in vivo and in vitro, suggesting new pathways in the emerging role of testis in the regulation of bone metabolism.
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
We have reviewed the evidence of the gut microbiome as a driving force in the development of obesity and type 2 diabetes mellitus. Considering overlap in potential mechanisms, the role of the gut microbiome in type 1 diabetes mellitus will also be addressed.
Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion
Insulin secretion was evaluated in adults who have been exposed in utero to maternal T1D. Only women (not men) exhibited decreased insulin secretion in response to intravenous glucose.